• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


rare disease

  1. OXBRYTA NO MORE RARE DISEASE DONE???

    Oxbryta Reps. Share the story been told about our jobs!
    • anonymous
    • Thread
    • rare disease
    • Replies: 11
    • Forum: Pfizer

  2. Derm Rare Disease Openings

    What is the med, please? Timeline on hiring a sales force? Anyone interviewing already? Thanks!
Top Bottom
Back